WELLNESS & HEALTH
IS ABOUT:- Ascension wellness, shift symptoms handling, balancing body, mind,spirit in galactic global shift, Recommending medicines,nutrition,counselling, therapies etc. that work so as to achieve a sound body, sound mind, sound spirit in a sound environment.
We provide Systematic Regimen/plan and management of diseases and ailments via diet, therapy, counselling or medication designed to improve and maintain the health and well being of individuals and groups based on tried and tested modern medicine & complimentary medicines. We also consult on preventive and social medicine.
Dr. Tony Verma
————————————————-<<<<<<>>>>>———————————————–
When mind, body, and spirit are in harmony, happiness is the natural result. Signs of the absence of harmony, on the other hand, are discomfort, pain, depression, anxiety, and illness in general. Unhappiness is a form of feedback. It signals that disharmony has entered the field somewhere–either in mind, body, or spirit. Awareness has become disconnected. Only when we look at the situation in this holistic way can we link health, wholeness, and holiness, for all three share the same root word, and all three share the same state of harmony or disharmony.
Pure Love & Kindness to yourself
Have gentleness, Kindness and pure love to your inner being both mental & spiritual. It will turn resistance into harmony.
Practice Here & Now
Letting go of anything not directly in front of me—in my face—at this very moment. Detaching from any relations or things that occupy my awareness and take me away from being fully present in the here and now. Practice The affirmation “Here’s my mind, here’s my awareness, in the here and now”.
Antimicrobial resistance: in terms politicians understand—via LANCET
Last week brought renewed interest in the worldwide antimicrobial resistance crisis, which has a potentially devastating effect on human beings, livestock, and the global economy. This interest was stimulated by the publication on Dec 11, 2014, of Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, from the Review of Antimicrobial Resistance, led by economist Jim O’Neill and informed by two reports prepared by consultants KPMG and RAND Europe; and by the first annual progress and implementation report on antimicrobial resistance by the UK Government, following their 2013 5-year strategy plan.
The O’Neill review estimates that 300 million people will die as a result of drug resistance during the next 35 years. This would have a catastrophic knock on effect on the world’s economy, reducing global GDP by 2–3·5% more than it should otherwise have been in 2050. In addition to antibiotic resistance, the review projects figures for resistance to antimalarial, HIV, and tuberculosis drugs. However, the consultants admit the data are unreliable, and state that: “These were considered as proxies in the absence of better data or forecasting tools; much more details and robust work will no doubt be done by academic researchers and clinicians in the future”. The authors also state that their: “teams experienced significant problems with data collection because of the lack of consistent sources monitoring the number of bacterial infections globally”. As such, reliance on the accuracy of these figures should be treated cautiously. The RAND Europe report has been peer reviewed according to their internal quality assurance procedures, but independent peer review and publication in the scientific literature would be necessary for their conclusions to be taken as anything other than preliminary and provisional. An opportunity has been missed in not publishing these papers in scientific journals concurrently with the final O’Neill report.
The government report centres around recommendations for seven areas, with key achievements and action points of the first year’s progress outlined. Of these, the strengthening of international collaboration will underlie the eventual successful tackling of antimicrobial resistance. Much progress on international collaboration is already being made, in particular through the Transatlantic Task Force on Antimicrobial Resistance. In international circles, the UK is presenting a unified approach from the Chief Medical Officer and the Chief Veterinary Officer, and together with bodies such as WHO, the UN Food and Agriculture Organization, and the World Economic Forum, a steering committee is aiming to put antimicrobial resistance on the international agenda, and to raise interest and support for reducing the use of antimicrobial drugs at all levels of society from local through to global.
Publication of these papers has been followed by a high-level One Health Colloquium (Dec 18–19 in London UK), which will lead to practical recommendations. The One Health group recognises that there is a shared outcome of health for all and fosters cross-disciplinary cooperation at the intersection between human and animal ecosystems. This meeting has the potential to be more influential and effective than the government report in achieving tangible goals, and in creating the necessary mechanisms for international collaboration. The timing is fortuitous in that high-level leaders and scientists from human and animal health sectors, industry representatives, and government and international bodies, including the World Bank and WHO, are in a position to identify the data and evidence needed to recommend actions that will properly address contentious issues, such as industry cost-effectiveness. Two underlying themes to the One Health meeting agenda exist: first, that the antimicrobial resistance crisis must not become a blame game—human beings and animals occupy the same ecosystems; and second, that there needs to be an understanding of the economics and mathematics involved: industry voices will be heard and understanding the potential economic impact is a necessity.
In 2013, The Lancet Infectious Diseases Commission on antibiotic resistance called for coordinated action, politically, nationally, and internationally. The next milestone is a Global Action Plan due to be ratified at the World Health Assembly in May, 2015, and the push for the inclusion of antimicrobial resistance as a post-2015 sustainable development goal. The first phase of work outlined in last week’s reports might not be as scientifically rigorous or informed by evidence as one might hope, and there now needs to be further and better engagement by scientists to sharpen the data and the message. The One Health meeting and the follow-up report with recommended actions should help this to materialise.
CelestialCosmic Source 